Joel Lewis

Track

Insider profile

Currently holds a position at Galectin Therapeutics Inc

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 52% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Galectin Therapeutics Inc Jan. 1, 2017 -
Joel Lewis's trades of Galectin Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
4.20
Quantity 84,000
Value US$352,800
Transaction date
Proposed sale
Price
7.06
Quantity 40,000
Value US$282,244
Transaction date
Proposed sale
Price
6.36
Quantity 54,250
Value US$345,063
Transaction date
Proposed sale
Price
1.04
Quantity 56,000
Value US$58,240
Transaction date
Purchase
Price
4.28
Quantity 12,849 +19.5%
Value US$54,994
Transaction date
Purchase
Price
4.81
Quantity 1,000 +1.6%
Value US$4,805
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-06 2026-01-06
PlS Planned sale
44,781 -35.2%
128.94
US$4,538,773 		44,781 -35.2% 128.94 US$4,538,773
2026-01-06 2026-01-05
PlS Planned sale
67,647 +13.2%
400.47
US$986,819 		67,647 +13.2% 400.47 US$986,819
2026-01-06 2026-01-02
PlS Planned sale
48,248 +30.1%
108.47
US$1,037,081 		48,248 +30.1% 108.47 US$1,037,081
2026-01-02 2026-01-02
PrS Proposed sale
84,000
4.20
US$352,800 		84,000 4.20 US$352,800
2025-12-19 2025-12-17
PlS Planned sale
7,829 -0.9%
7.06
US$55,241 		7,829 -0.9% 7.06 US$55,241
2025-12-17 2025-12-17
PrS Proposed sale
40,000
7.06
US$282,244 		40,000 7.06 US$282,244
2025-11-19 2025-11-18
PlS Planned sale
6,783 -0.8%
6.15
US$41,723 		6,783 -0.8% 6.15 US$41,723
2025-11-19 2025-11-17
PlS Planned sale
15,680 -1.8%
6.04
US$94,643 		15,680 -1.8% 6.04 US$94,643
2025-11-12 2025-11-10
PlS Planned sale
1,867 -0.2%
6.03
US$11,252 		1,867 -0.2% 6.03 US$11,252
2025-11-07 2025-11-05
PlS Planned sale
200 -0.0%
6.00
US$1,200 		200 -0.0% 6.00 US$1,200
2025-11-05 2025-11-04
PlS Planned sale
14,420 -1.7%
6.07
US$87,529 		14,420 -1.7% 6.07 US$87,529
2025-11-05 2025-11-03
PlS Planned sale
1,300 -0.2%
6.01
US$7,813 		1,300 -0.2% 6.01 US$7,813
2025-09-15 2025-09-12
PlS Planned sale
14,000 -1.7%
6.36
US$89,048 		14,000 -1.7% 6.36 US$89,048
2025-09-12 2025-09-12
PrS Proposed sale
54,250
6.36
US$345,063 		54,250 6.36 US$345,063
2024-12-26 2024-12-23
PlS Planned sale
56,000 -5.9%
0.89
US$49,610 		56,000 -5.9% 0.89 US$49,610
2024-12-23 2024-12-23
PrS Proposed sale
56,000
1.04
US$58,240 		56,000 1.04 US$58,240
2024-04-25 2024-04-24
B Purchase
1,000 +100.0%
3.39
US$3,390 		1,000 +100.0% 3.39 US$3,390
2024-04-25 2024-04-24
B Purchase
1,000 +100.0%
3.39
US$3,390 		1,000 +100.0% 3.39 US$3,390
2023-02-21 2023-02-16
B Purchase
1,000 +inf%
1.52
US$1,520 		1,000 +inf% 1.52 US$1,520
2019-06-03 2019-05-31
B Purchase
12,849 +19.5%
4.28
US$54,994 		12,849 +19.5% 4.28 US$54,994
2019-04-08 2019-04-05
B Purchase
667 +1.0%
4.82
US$3,214 		667 +1.0% 4.82 US$3,214
2019-02-11 2019-02-07
B Purchase
1,000 +1.6%
4.48
US$4,484 		1,000 +1.6% 4.48 US$4,484
2019-01-30 2019-01-29
B Purchase
1,000 +1.6%
4.81
US$4,805 		1,000 +1.6% 4.81 US$4,805